BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: You L, Wu W, Wang X, Fang L, Adam V, Nepovimova E, Wu Q, Kuca K. The role of hypoxia-inducible factor 1 in tumor immune evasion. Med Res Rev 2021;41:1622-43. [PMID: 33305856 DOI: 10.1002/med.21771] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen H, Chen X, Ping Z, Jiang X, Ge M, Ma J, Yu W. Promotion Effect of Angelica Sinensis Extract on Angiogenesis of Chicken Preovulatory Follicles in Vitro. Poultry Science 2022. [DOI: 10.1016/j.psj.2022.101938] [Reference Citation Analysis]
2 Zhan B, Dong X, Yuan Y, Gong Z, Li B. hZIP1 Inhibits Progression of Clear Cell Renal Cell Carcinoma by Suppressing NF-kB/HIF-1α Pathway. Front Oncol 2021;11:759818. [PMID: 34926261 DOI: 10.3389/fonc.2021.759818] [Reference Citation Analysis]
3 Mortezaee K, Majidpoor J. (Im)maturity in Tumor Ecosystem. Front Oncol 2022;11:813897. [DOI: 10.3389/fonc.2021.813897] [Reference Citation Analysis]
4 Spirina L, Avgustinovich A, Afanas'ev S, Volkov M, Dobrodeev A, Cheremisina O, Kostromitsky D. PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation. Int J Mol Sci 2021;22:11176. [PMID: 34681840 DOI: 10.3390/ijms222011176] [Reference Citation Analysis]
5 Pansy K, Uhl B, Krstic J, Szmyra M, Fechter K, Santiso A, Thüminger L, Greinix H, Kargl J, Prochazka K, Feichtinger J, Deutsch AJ. Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions. Int J Mol Sci 2021;22:13311. [PMID: 34948104 DOI: 10.3390/ijms222413311] [Reference Citation Analysis]
6 Anduran E, Dubois LJ, Lambin P, Winum JY. Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 - 2021. Expert Opin Ther Pat 2021;:1-12. [PMID: 34241566 DOI: 10.1080/13543776.2021.1954617] [Reference Citation Analysis]
7 Feng Z, Qian H, Li K, Lou J, Wu Y, Peng C. Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma. Front Mol Biosci 2021;8:676291. [PMID: 34095229 DOI: 10.3389/fmolb.2021.676291] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhang Y, Yang F, Peng X, Li X, Luo N, Zhu W, Fu M, Li Q, Hu G. Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment. Front Cell Dev Biol 2021;9:665364. [PMID: 33959617 DOI: 10.3389/fcell.2021.665364] [Reference Citation Analysis]
9 Yang X, Weng X, Yang Y, Zhang M, Xiu Y, Peng W, Liao X, Xu M, Sun Y, Liu X. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer. Aging (Albany NY) 2021;13:19486-509. [PMID: 34341184 DOI: 10.18632/aging.203360] [Reference Citation Analysis]
10 Zhuang H, Wang S, Chen B, Zhang Z, Ma Z, Li Z, Liu C, Zhou Z, Gong Y, Huang S, Hou B, Chen Y, Zhang C. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Front Immunol 2021;12:790661. [PMID: 34925373 DOI: 10.3389/fimmu.2021.790661] [Reference Citation Analysis]
11 Pei P, Shen W, Zhang Y, Zhang Y, Qi Z, Zhou H, Liu T, Sun L, Yang K. Radioactive nano-oxygen generator enhance anti-tumor radio-immunotherapy by regulating tumor microenvironment and reducing proliferation. Biomaterials 2022;280:121326. [PMID: 34953386 DOI: 10.1016/j.biomaterials.2021.121326] [Reference Citation Analysis]
12 Liu J, Peng X, Yang S, Li X, Huang M, Wei S, Zhang S, He G, Zheng H, Fan Q, Yang L, Li H. Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-021-00816-w] [Reference Citation Analysis]
13 Mu Q, Najafi M. Modulation of the tumor microenvironment (TME) by melatonin. Eur J Pharmacol 2021;907:174365. [PMID: 34302814 DOI: 10.1016/j.ejphar.2021.174365] [Reference Citation Analysis]
14 Zhang L, Zhang H, Xie J, Wang X. Identification of Gene Co-Expression Modules and Core Genes Related to Immune Disorders in Major Depression Disorder. Int J Gen Med 2021;14:7983-93. [PMID: 34785941 DOI: 10.2147/IJGM.S336686] [Reference Citation Analysis]
15 Janji B, Chouaib S. "Suffocating" tumors by blocking adaptation to hypoxia: a new headway in melanoma immunotherapy. Oncoimmunology 2021;10:1968611. [PMID: 34527430 DOI: 10.1080/2162402X.2021.1968611] [Reference Citation Analysis]
16 Pei H, Guo W, Peng Y, Xiong H, Chen Y. Targeting key proteins involved in transcriptional regulation for cancer therapy: Current strategies and future prospective. Med Res Rev 2022. [PMID: 35312190 DOI: 10.1002/med.21886] [Reference Citation Analysis]
17 He F, Xiao H, Cai Y, Zhang N. ATF5 and HIF1α cooperatively activate HIF1 signaling pathway in esophageal cancer. Cell Commun Signal 2021;19:53. [PMID: 33980247 DOI: 10.1186/s12964-021-00734-x] [Reference Citation Analysis]
18 Smith PJ, McKeown SR, Patterson LH. Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs). IUBMB Life 2022. [PMID: 35499745 DOI: 10.1002/iub.2619] [Reference Citation Analysis]
19 Shao J, Zhang B, Kuai L, Li Q. Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients. Bioengineered 2021;12:6186-200. [PMID: 34486476 DOI: 10.1080/21655979.2021.1973874] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang L, Kuca K, You L, Zhao Y, Musilek K, Nepovimova E, Wu Q, Wu W, Adam V. Signal transducer and activator of transcription 3 signaling in tumor immune evasion. Pharmacol Ther 2021;:107969. [PMID: 34450232 DOI: 10.1016/j.pharmthera.2021.107969] [Reference Citation Analysis]
21 Capitani N, Patrussi L, Baldari CT. Nature vs. Nurture: The Two Opposing Behaviors of Cytotoxic T Lymphocytes in the Tumor Microenvironment. Int J Mol Sci 2021;22:11221. [PMID: 34681881 DOI: 10.3390/ijms222011221] [Reference Citation Analysis]
22 Kleibert M, Majka M, Łakomska K, Czystowska-kuźmicz M. Extracellular Vesicles—A New Potential Player in the Immunology of Renal Cell Carcinoma. JPM 2022;12:772. [DOI: 10.3390/jpm12050772] [Reference Citation Analysis]
23 Domènech M, Hernández A, Plaja A, Martínez-Balibrea E, Balañà C. Hypoxia: The Cornerstone of Glioblastoma. Int J Mol Sci 2021;22:12608. [PMID: 34830491 DOI: 10.3390/ijms222212608] [Reference Citation Analysis]
24 Bailly C. Anticancer Targets and Signaling Pathways Activated by Britannin and Related Pseudoguaianolide Sesquiterpene Lactones. Biomedicines 2021;9:1325. [PMID: 34680439 DOI: 10.3390/biomedicines9101325] [Reference Citation Analysis]
25 Yuan H, Lu Y, Chan YT, Zhang C, Wang N, Feng Y. The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development. Cancers (Basel) 2021;13:5700. [PMID: 34830854 DOI: 10.3390/cancers13225700] [Reference Citation Analysis]
26 Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K, Mirzaei S, Sethi G. Non-coding RNAs and macrophage interaction in tumor progression. Crit Rev Oncol Hematol 2022;:103680. [PMID: 35405273 DOI: 10.1016/j.critrevonc.2022.103680] [Reference Citation Analysis]
27 Jiang H, Li M, Du K, Ma C, Cheng Y, Wang S, Nie X, Fu C, He Y. Traditional Chinese Medicine for adjuvant treatment of breast cancer: Taohong Siwu Decoction. Chin Med 2021;16:129. [PMID: 34857023 DOI: 10.1186/s13020-021-00539-7] [Reference Citation Analysis]
28 Li J, Zhang G, Liu CG, Xiang X, Le MTN, Sethi G, Wang L, Goh BC, Ma Z. The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy. Theranostics 2022;12:87-104. [PMID: 34987636 DOI: 10.7150/thno.64096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Yan J, Huang YJ, Huang QY, Liu PX, Wang CS. Comprehensive analysis of the correlations of S100B with hypoxia response and immune infiltration in hepatocellular carcinoma. PeerJ 2022;10:e13201. [DOI: 10.7717/peerj.13201] [Reference Citation Analysis]